Reporter

Jonathan Saltzman

Jonathan Saltzman has worked at the Boston Globe since 2002 and currently covers biotechnology and the life sciences. He previously covered the federal and state courts and then spent six years on the Spotlight Team. He was part of a team that won a George Polk Award in 2012 for a series on the state’s unusually high rate of acquittal at bench trials for drunk driving. He was also a runner-up for other awards, including a Pulitzer Prize and Goldsmith Prize for Investigative Reporting, for a series of stories about dangerous off-campus housing for college students in Boston. Saltzman, a graduate of Brooklyn College, has worked at the Providence Journal, USA Today, the Rochester Democrat & Chronicle, and the Poughkeepsie Journal. He also co-hosted a daily magazine show for the NPR station in Rhode Island. He lives in Providence.

Latest stories

Boston drug-pricing watchdog group is ‘mouse that roared’

By , Globe Staff

ICER researchers spend about eight months studying how well a medicine works and whether it might reduce other health care costs, then publicize their findings in the hopes of getting drug makers to set a fair price.

Comet Therapeutics raises $28.5m for research into metabolic disorders

By , Globe Staff

Cambridge company aims to tackle a range of conditions, from MS to arthritis.

Ironwood Pharmaceuticals moving its headquarters from Cambridge to Boston

By , Globe Staff

The drug company will move from the sleek curved building it occupies on Binney Street to 39,000 square feet at 100 Summer St.

Fast-growing Vericel finds success on two fronts: knee surgery and burn care

By , Globe Staff

The Cambridge biotech’s market value has grown from $50 million to $670 million in five years.